A retrospective study of the CHOP, CHOPE, and CHOPE/G regimens as the first-line treatment of peripheral T-cell lymphomas

被引：0
|
作者：
Xuyan Liu
Mingzi Yang
Meng Wu
Wen Zheng
Yan Xie
Jun Zhu
Yuqin Song
Weiping Liu
机构：
[1] Peking University Cancer Hospital and Institute,Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Lymphoma
来源：
Cancer Chemotherapy and Pharmacology | 2019年 / 83卷
关键词：
Peripheral T-cell lymphomas; Chemotherapy; CHOP; Etoposide; Gemcitabine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：443 / 449
页数：6
相关论文
共 50 条
  • [1] A retrospective study of the CHOP, CHOPE, and CHOPE/G regimens as the first-line treatment of peripheral T-cell lymphomas
    Liu, Xuyan
    Yang, Mingzi
    Wu, Meng
    Zheng, Wen
    Xie, Yan
    Zhu, Jun
    Song, Yuqin
    Liu, Weiping
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019, 83 (03) : 443 - 449
  • [2] Comparison of gemcitabin, cisplatin, and dexamethasone (GDP), CHOP, and CHOPE in the first-line treatment of peripheral T-cell lymphomas
    Jia, Bo
    Hu, Shaoxuan
    Yang, Jianliang
    Zhou, Shengyu
    Liu, Peng
    Qin, Yan
    Gui, Lin
    Yang, Sheng
    Lin, Hua
    Zhang, Changgong
    Xing, Puyuan
    Wang, Lin
    Dong, Mei
    Zhou, Liqiang
    Sun, Yan
    He, Xiaohui
    Shi, Yuankai
    HEMATOLOGY, 2016, 21 (09) : 536 - 541
  • [3] Comparison of CHOP vs CHOPE for treatment of peripheral T-cell lymphoma: a meta-analysis
    Deng, Shu
    Lin, Shenyun
    Shen, Jianping
    Zeng, Yuqing
    ONCOTARGETS AND THERAPY, 2019, 12 : 2335 - 2342
  • [4] Comparison of Efficacy and Safety of Gdpt and CHOP in First-Line Treatment of Peripheral T-Cell Lymphoma
    Zhao, Kangjin
    Zhang, Mingzhi
    BLOOD, 2024, 144
  • [5] Alemtuzumab in combination with CHOP and ESHAP as first-line treatment in peripheral T-cell lymphoma.
    Intragumtornchai, Tanin
    Bunworasate, Udomsak
    Nakorn, Thanyaphong Na
    Rojnuckarin, Ponlapat
    BLOOD, 2006, 108 (11) : 268B - 268B
  • [6] Alemtuzumab, fludarabine, cyclophosphamide, and doxorubicin (campath-FCD): An effective first-line treatment in peripheral T-cell lymphomas
    Weidmann, E
    Hess, G
    Krause, S
    Hebart, H
    Dreyling, M
    Subklewe, M
    Falge, C
    Atmaca, A
    Jaeger, E
    Mitrou, P
    ANNALS OF ONCOLOGY, 2005, 16 : 131 - 132
  • [7] Redefining the role of etoposide in first-line treatment of peripheral T-cell lymphoma
    Kim, Young Ae
    Byun, Ja Min
    Park, Keeho
    Bae, Gi Hwan
    Lee, Dukhyoung
    Kim, Dong Sook
    Yoon, Sung-Soo
    Koh, Youngil
    BLOOD ADVANCES, 2017, 1 (24) : 2138 - 2146
  • [8] Bortezomib in combination with CHOP as first-line treatment for patients with stage III/IV peripheral T-cell lymphomas: A multicentre, single-arm, phase 2 trial
    Kim, Seok Jin
    Yoon, Dok Hyun
    Kang, Hye Jin
    Kim, Jin Seok
    Park, Seong Kyu
    Kim, Hyo Jung
    Lee, Jeeyun
    Ryoo, Baek-Yeol
    Ko, Young Hyeh
    Huh, Jooryung
    Yang, Woo Ick
    Kim, Hee Kyung
    Min, Soo Kee
    Lee, Seung-Sook
    Do, In-Gu
    Suh, Cheolwon
    Kim, Won Seog
    EUROPEAN JOURNAL OF CANCER, 2012, 48 (17) : 3223 - 3231
  • [9] Autologous stem cell transplantation as first-line therapy in peripheral T-cell lymphomas. A prospective multicenter study.
    Reimer, P
    Ruediger, T
    Schertlin, T
    Geissinger, E
    Weissinger, F
    Einsele, H
    Mueller-Hermelink, HK
    Wilhelm, M
    BLOOD, 2005, 106 (11) : 586A - 587A
  • [10] Autologous Stem-Cell Transplantation As First-Line Therapy in Peripheral T-Cell Lymphomas: Results of a Prospective Multicenter Study
    Reimer, Peter
    Ruediger, Thomas
    Geissinger, Eva
    Weissinger, Florian
    Nerl, Christoph
    Schmitz, Norbert
    Engert, Andreas
    Einsele, Hermann
    Mueller-Hermelink, Hans Konrad
    Wilhelm, Martin
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (01) : 106 - 113
12345